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of Biochemistry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New JerseyABSTRACT Missense mutations, which replace one Gly with a larger residue in the repeating sequence of the type I collagen
triple helix, lead to the hereditary bone disorder osteogenesis imperfecta (OI). Previous studies suggest that these mutations
may interfere with triple-helix folding. NMR was used to investigate triple-helix formation in a series of model peptides where
the residue replacing Gly, as well as the local sequence environment, was varied. NMR measurement of translational diffusion
coefficients allowed the identification of partially folded species. WhenGly was replaced by Ala, the Ala residue was incorporated
into a fully folded triple helix, whereas replacement of Gly by Ser or Arg resulted in the presence of some partially folded species,
suggesting a folding barrier. Increasing the triple-helix stability of the sequence N-terminal to a Gly-to-Ser replacement allowed
complete triple-helix folding, whereas with the substitution of Arg, with its large side chain, the peptide achieved full folding only
after flexible residues were introduced N-terminal to the mutation site. These studies shed light on the factors important for
accommodation of Gly mutations within the triple helix and may relate to the varying severity of OI.INTRODUCTIONMutations in Type I collagen, the major structural compo-
nent of skin, bone, tendon, and ligament, lead to osteogen-
esis imperfecta (OI), or brittle bone disease, a hereditary
disorder distinguished by fragile bones (1–4). Type I
collagen is a heterotrimer, consisting of two a1 chains and
one a2 chain. Like all collagens, type I adopts a character-
istic triple-helix conformation consisting of three extended
polyproline-II-like chains supercoiled about a common
axis with one-residue staggering (5,6). The close packing
of the three chains can only accommodate Gly as every third
residue, generating the repetitive (Gly-Xaa-Yaa)n sequence
pattern (5,6). The repeating tripeptide sequence is perfectly
maintained throughout the 1014-residue-long triple-helix
domain of type I collagen (7,8), and even a single Gly muta-
tion at any site results in OI. More than 600 cases of OI have
been reported to result from missense mutations that replace
a Gly with another bulkier amino acid in the a1 chain, and
>400 cases exist for the a2 chain of type I collagen (3,9).
Defective folding of collagen has been implicated in the
etiology of OI. A delay in folding was first suggested based
on the observation that OI collagens contain increased post-
translational modifications, which can only take place on
unfolded chains (10). More recently, abnormal folding has
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0006-3495/11/07/0449/10 $2.00and unfolded protein response in an OI mouse model
(11,12). The phenotype of OI is highly variable, ranging
from mild cases with multiple fractures to perinatal lethal
cases (2,3). Factors thought to be related to this variable
severity include the identity of the residue replacing Gly,
the neighboring sequences around the Gly mutation site,
and the proximity of the mutation to interaction sites or
salt bridges (13–21), but it is not clear how these factors
impact triple-helix conformation and dynamics.
Triple-helical peptides with OI mutations are useful for
evaluating the effects of mutations in a systematic, well
controlled environment and have proved amenable to
biophysical characterization (14,22–26). Introduction of
mutationswithin a host-guest (Gly-Pro-Hyp)8 peptide system
showed that the degree of triple-helix destabilization de-
pended on the identity of the residue replacing Gly: the order
of destabilization is Ala, Ser< Cys<Arg<Val<Glu, Asp
(21). Although recent studies on OI collagens suggest that
their thermal stability is not strongly dependent on the residue
replacing Gly (15), the order of destabilization in peptides
does show a correlation with the severity and lethality of OI
mutations (20,21), which could relate to their effect on
folding. NMR studies on triple-helix peptides are chal-
lenging, since the characteristic rodlike shape and repeating
Gly-Xaa-Yaa sequences result in resonance broadening and
overlapping (27). Despite these challenges, useful informa-
tion has been gained from NMR studies of peptide models
for native andmutant collagens using selectively 15N-labeled
residues, distances derived from nuclear Overhauser effects,
dynamics using hydrogen exchange, temperature-dependent
amide proton chemical shifts, relaxation times, and, recently,
NMR diffusion experiments (17,25,27–31).doi: 10.1016/j.bpj.2011.06.017
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residues have allowed characterization of the perturbations
at an OI mutation site as well as at sites N-terminal or
C-terminal to it (14,32–34). For instance, peptide T1-892,
which contains six triplets from the a1(I) chain (residues
892–909, GPAGPAGPVGPAGARGPA) at the N-terminus
and a stabilizing (GPO)4 sequence at the C-terminus, forms
a stable triple helix, and introduction of a Gly-to-Ala or Gly-
to-Ser substitution at residue 901, modeling an OI mutation,
maintains the stable C-terminal triple helix but has a disor-
dered region N-terminal to the mutation (32). The presence
of a more stabilizing N-terminal sequence, GPO(GAO)3
(creating a peptide denoted as T1-898), allows complete
folding in the presence of the Gly-to-Ala mutation (33),
showing the importance of the surrounding sequence.
Recent folding studies suggest that when Gly is replaced
by Ala or Ser in T1-898, a less stable, nonnative structure
is formed initially before the final folded state (35).
NMR diffusion experiments have been developed in our
laboratory to explore the low population of intermediate
species that are in equilibrium with the unfolded and fully
triple-helical states for collagen-like peptides (25). If there
are partially folded molecules in which the labeled residue
is disordered within a trimer species, then the translational
diffusion coefficients of the disordered peaks will be
reduced, reflecting their presence in a larger trimer species
(25). Such diffusion experiments are applied here to a set
of peptides that model Gly mutations to clarify the sequence
constraints that lead partially folded species to accumulate
in the presence of a mutation. Our data suggest that the
ability of the peptide to fully form a triple helix depends
on the identity of the residue replacing Gly, as well as on
the stability of the sequence N-terminal to the mutation.
Interestingly, it appears that replacement of Gly by Arg,
which has a very large side chain, requires a nearby flexible
sequence to fold completely.MATERIALS AND METHODS
Sample preparation
Peptides were synthesized by the Tufts University Core Facility (Boston,
MA) and were purified on a reverse-phase high-pressure liquid chromato-
graphy system (Shimadzu, Columbia, MD) with a C-18 column. The
identities of all peptides were confirmed by mass spectrometry using
matrix-assisted laser desorption ionization time of flight.Circular dichroism spectroscopy
Circular dichroism (CD) spectra were recorded on an Aviv model 62DS
spectrophotometer (Aviv Biomedical, Lakewood, NJ). Cells of path length
0.1 cm were used, and the temperature of the cells was controlled using
a Peltier thermoelectric temperature controller (Hewlett-Packard, Palo
Alto, CA). Unless explicitly stated otherwise, samples were prepared
with a concentration of 1 mg/mL in 20 mM phosphate-buffered saline
(PBS) (10 mM NaH2PO4, 10 mM Na2HPO4, and 150 mM NaCl) at pH
7. Peptide concentrations were determined by tyrosine absorbance atBiophysical Journal 101(2) 449–458275 nm using 3275 ¼ 1400 M1cm1. CD was used to track melting transi-
tions by monitoring the ellipticity at 225 nm as a function of temperature
from 0C to 60C. Standard procedure of a rate of 0.3C/min and a 2-
min equilibration time was employed (36). Peptides were equilibrated at
0C for at least 40 h before all melting experiments.NMR experiments
T1-898 peptide sets were synthesized with 15N-labeled amino acids at
selective positions for NMR characterization (Table S1 in the Supporting
Material). Peptide T1-898 was selectively 15N-labeled at positions G7,
A18, and G28, and peptide T1-898(G16A) was labeled at positions G7,
A16, and G28. Peptides T1-898(G16S) and GPOT1-898(G16S) were
labeled at positions G7, V15, A18, and G28; and G7, V15, A18, and
G22, respectively. Peptides T1-898(G16R), GPOT1-898(G16R), and
GAAT1-898(G16R) were labeled at positions G7, G13, and G28; G7,
V15, A18, and G22; and G7, A15, and G22, respectively (Table S1).
Samples were prepared in 10% D2O/90% H2O with a concentration of
6 mM at pH adjusted to ~2.5 by addition of hydrochloric acid.
NMR experiments were performed on an INOVA 500 or 600 MHz spec-
trometer (Varian, Palo Alto, CA). 1H-15N heteronuclear single quantum
coherence (HSQC) was performed at 0C (5C for peptide GPOT1-
898(G16S)). For peptide GAAT1-898(G16R), a hydrogen-exchange exper-
iment was performed at 0C to solve the overlapping problem of G22. The
peptide was lyophilized and re-dissolved in 100% D2O to exchange out the
protons of the disordered state. As the NH of Gly in the disordered state
exchanged much faster than those in the triple helix, after several hours
in D2O, the intensities of disordered resonances were significantly
decreased compared with trimer resonances, giving us an opportunity to
observe the trimer resonances of G22.
Residue-specific translational diffusion measurements were performed as
described before (25). Experiments employing a convection-compensated
light-emitting diode followed by HSQC (CCLED-HSQC) were used to
measure the residue-specific diffusion coefficients of the selectively labeled
peptides at 0C (5C for peptide GPOT1-898(G16S)) and 40C. All the
samples were equilibrated for >24 h before the diffusion experiments.
Peptide GPOT1-898(G16S) has weak disordered peaks at low temperature,
and satisfactory data could be achieved only at 5C. The gradient strength
was calibrated on a standard doped 1% H2O in 99% D2O sample using the
value 1.90  109 m2 s1 for the diffusion coefficient of HDO at 25C
(37,38).
All data were processed using the FELIX 2004 software package (MSI,
San Diego, CA). Data analysis of translational diffusion measurements was
conducted as described previously (25). The diffusion coefficients at
temperature T (0C or 5C) were normalized to values at 40C by using
the Stokes-Einstein equation, Dnormalized,T ¼ DT  313.15  hT/(T 
h40C), where DT is the directly measured diffusion coefficient at T, and
hT is the viscosity calculated for the solution of 90% H2O and 10% D2O
at a specific temperature (39). Then, a ratio of Dnormalized,T to D40C was
calculated as the normalized diffusion coefficient for each residue, denoted
as DM,T (DM0C in the case of all peptides except GPOT1-898(G16S), where
it was DM5C). The error of DM,T was calculated as
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
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The relative populations of partially folded species and pure monomer for
each labeled residue were derived from a two-parameter fitting, assuming
slow exchange rate between partially folded species and pure monomer
on the diffusion timescale (25).
NMR Studies of Peptide Models of OI 451Some potential problems, such as cross-relaxation and exchange of the
amide protons with water, could be associated with the diffusion measure-
ments (40–46). To reduce the oscillatory modulation and signal attenua-
tion arising from cross-relaxation and chemical exchange, the bipolar
pulse pairs in the CCLED-HSQC were used (43–46). The experiments
were performed at low pH (2.5) to suppress the exchange process of the
amide protons with water. At pH 2.5, even at 40C, the water-amide
proton exchange rate was very slow relative to the diffusion timescale
based on theoretical calculations and NMR CLEANEX-PM experiments,
suggesting little potential effect (47,48). Sample volumes were minimized
by using shigemi tubes to decrease artifacts due to nonlinearity of the
pulsed field gradients. A control experiment with a short diffusion delay
(D) of 50 ms was done at 10C and 40C, and revealed essentially the
same diffusion coefficients as those measured with a 280-ms delay, indi-
cating that the diffusion measurements were not affected by the potential
artifacts.RESULTS
Residue-specific NMR diffusion experiments were per-
formed to investigate the structural disruption caused by re-
placing a Gly in the repeating sequence of peptide T1-898
with Ala, Ser, Arg, or Asp, and to characterize the nature
of the molecular species that arise from different sub-
stitutions (Table S1). Previous CD studies of these peptides
have shown that the Ser replacement causes greater destabi-
lization of the triple helix than the Ala replacement, whereas
Arg and Asp do not allow complete folding of the triple
helix (35).Equilibrium conformations of T1-898
and T1-898(G16A)
The HSQC spectrum of peptide T1-898 at 0C contains
features typical of a triple-helical conformation, consistent
with previous results (33). 15N-labeled residues at three
different positions (G7, A18, and G28) show one or more
triple-helical resonances in addition to resonances due to
a disordered form (Fig. 1 A). Triple-helical resonances are
distinguished from disordered resonances by their much
faster 15N transverse relaxation rates (R2). Unlike disor-
dered resonances, triple-helical resonances disappear at
40C, a temperature higher than the melting temperatures
of the peptides (data not shown). Disordered resonances,
which were referred to simply as monomer resonances in
our earlier studies, are used here to clarify and emphasize
that these resonances may represent unfolded monomer as
well as unfolded regions in a partially folded trimer. Other
minor resonances observed in the HSQC spectrum arise
due to cis-trans isomerization of Gly-Pro and Pro-Hyp
bonds in the peptide in the unfolded states (49). The disor-
dered resonances with the highest intensities have been
assigned, and they represent the major component of
cis-trans conformers: the all-trans form. The observation
of distinct disordered and triple-helical resonances for all
residues supports the concept of a native triple-helical-
to-disordered equilibrium in solution.NMR translational diffusion coefficients are used to
detect equilibrium intermediates in the self-associating
triple-helical peptides. If there is a simple two-state equilib-
rium between disordered monomer species and fully folded
triple-helical trimer species, then the diffusion constants of
all disordered peaks will reflect the monomer state. If,
however, a given residue is in a disordered state within
a partially folded trimer, the diffusion constant will be
smaller than that of the monomer, since the trimer species
has very different hydrodynamic properties from the mono-
mer. This model of diffusion data analysis is based on the
premise that the disordered resonances originate from either
the completely unfolded monomer or unfolded parts of the
partially folded trimer, and this assumption is supported
by previous studies (25,32,34,50). NMR relaxation studies
of a peptide with a Gly-to-Ser mutation indicated that peaks
due to disordered residues arise primarily from the disor-
dered region in a partially folded species (32). NMR studies
have also shown that the nonuniform diffusion coefficients
observed for disordered resonances are best explained by
the overlapping chemical shifts of residues in unfolded
monomers and in disordered regions of partially folded
trimers (25).
Residue-specific translational diffusion measurements
were performed on the disordered peaks of the T1-898
peptide at 0C and 40C to characterize equilibrium species
in solution, according to the methodology developed by Li
et al. (25). We are not able to measure translational diffusion
coefficients of triple-helical resonances due to low sensi-
tivity. At 40C, when the protein is unfolded, the disordered
resonances represent the unfolded monomeric protein and
serve as a control for the disordered diffusion coefficient.
The diffusion coefficients are uniform at these high temper-
atures for all labeled positions within the T1-898 peptide,
consistent with sampling a similar averaged denatured shape
across the protein (Table S2). However, at a lower tempera-
ture such as 0C, disordered resonances may represent
a combination of pure monomers as well as unfolded
regions within partially folded species, resulting in reduced
diffusion coefficients. Therefore, comparing the values of
the diffusion coefficient of disordered residues at 0C with
those at 40C allows us to detect the existence of additional
species relative to pure monomer based on the diffusion
model. Moreover, this model, although qualitative, allows
us to make structural predictions about which region of
the peptide is disordered based on information about which
part of the protein has smaller diffusion coefficients. Peptide
T1-898 contains no Gly mutations, and all labeled residues
show normalized diffusion coefficients at 0C that are close
to 1, which is consistent with sampling a pure monomer
state (Fig. 1 E). Thus, the HSQC and diffusion experiments
support a two-state unfolded monomer (M) to fully folded
trimer (FT) equilibrium model.
The HSQC spectrum of peptide T1-898(G16A) shows
distinct triple-helical resonances for all labeled residuesBiophysical Journal 101(2) 449–458
FIGURE 1 Effect of Gly-to-Ala/Ser substitution on equilibrium conformations of peptide T1-898. (A–D) 1H-15N HSQC spectra of T1-898 (A),
T1-898(G16A) (B), T1-898(G16S) (C), and GPOT1-898(G16S) (D) at 0C. Peaks corresponding to the disordered and triple-helical states are denoted
by superscripts D and T, respectively. Disordered resonances, referred to simply as monomer resonances in our earlier studies, are used here to clarify
and emphasize that these resonances may represent M, as well as unfolded regions in a PFT. Minor disordered resonances arise due to cis-trans isomerization
in the unfolded state of the Pro/Hyp-rich chains (49). The assigned disordered resonances represent the major all-trans isomer. (E–H) Histograms of the
residue-specific translational diffusion coefficients of 15N-labeled residues in disordered states for peptide T1-898 (E), T1-898(G16A) (F), T1-898(G16S)
(G), and GPOT1-898(G16S) (H). Diffusion coefficients at 0C (5C for peptide GPOT1-898(G16S)) are normalized to those at 40C. Peptide GPOT1-
898(G16S) has weak disordered peaks at low temperature and satisfactory data could be achieved only at 5C. The black dashed lines represent the normal-
ized diffusion coefficients for M (theoretically with a value of 1) and native trimer (with a value of 0.58 for G28 in peptide T1-898(G16A)).
452 Xiao et al.at positions G7, A16, and G28 (Fig. 1 B), which is consis-
tent with previous studies showing that the replacement of
the central Gly with Ala results in a peptide that contains
the features of a fully folded triple helix (33). However,
normalized diffusion coefficients at 0C (DM0C) indicate
that this peptide contains more than a simple monomer/
trimer equilibrium. The DM0C values for G7 and G28
are ~1, indicating that the two terminal residues are not
in partially folded states and suggesting that the two ends
of the peptide are folded (Fig. 1 F). The much lower
DM0C of A16 suggests a triple-helical conformation with a
looser middle region. Hence, the peptide T1-898(G16A)
appears to have an intermediate partially folded trimer
species (PFT) in addition to the FT and M forms, andBiophysical Journal 101(2) 449–458the M/PFT ratio is quantified to be 1:1.2, indicating that
about half of the disordered chemical shift for residue
A16 is arising from a partially folded trimer.Effects of a GPO-rich renucleation sequence
on a Gly-to-Ser substitution
A peptide with a central Gly replaced by Ser (T1-
898(G16S)) models a mild case of OI resulting from
a Gly-to-Ser mutation at position 901 in the a1 chain of
type I collagen (3). The HSQC spectrum (Fig. 1 C) of
T1-898(G16S) at 0C shows distinct triple-helical reso-
nances for all four labeled residues, G7, V15, A18, and
G28, indicating that when a Ser replaces the Gly, the Ser
NMR Studies of Peptide Models of OI 453can be incorporated into a triple-helical conformation. The
residue-specific diffusion coefficients of the resonances cor-
responding to the disordered state (Fig. 1 G) indicate that
DM0C for G7, V15, and A18 are similar and <1, whereas
DM0C for G28 is ~1. The structural implications are that
T1-898(G16S) is a partially folded species whose con-
formation contains a folded C-terminus, and an unfolded
N-terminus and mutation site. Peptide T1-898(G16S)
contains some PFT, as well as M and FT, and the M/PFT
ratio is calculated as 1:1.8. One explanation for the
difference in the conformations of the two terminal ends
is that the C-terminus has the highly stable and stronger
nucleation sequence (GPO)4, whereas the N-terminus has
the less stable GPO(GAO)3 sequence (33).
Previous studies have suggested that triple-helix folding
starts from the C-terminal (GPO)4 sequence, whereas the
N-terminal sequence may constitute a renucleation
domain, which could be a crucial factor in the completion
of folding of triple helix N-terminal to a mutation (33,51).
Studies have also suggested that (GPO)4 is a more efficient
nucleation domain than GPO(GAO)3 (33). To create
a peptide with a Gly-to-Ser substitution that would be
less prone to fraying at the N-terminus, a new peptide
was designed with a more stabilizing (GPO)4 sequence
to replace the GPO(GAO)3. As expected, the thermal
stability of peptide GPOT1-898(G16S) increased signifi-
cantly to 28C compared to the Tm of 14.5C for T1-
898(G16S). The HSQC spectrum of GPOT1-898(G16S)
shows triple-helical resonances for the four labeled resi-
dues G7, V15, A18, and G22, indicating the presence of
FT (Fig. 1 D). The diffusion experiments were carried
out at 5C and 40C to study the disordered resonances
(Fig. 1 H), and they show that the values of DM5C for
G7, V15, A18, and G22 are all close to 1, suggesting
that the peptide has no partially folded species, only M
in equilibrium with FT.Effects of renucleation sequence and nearest
neighboring sequence on a Gly-to-Arg
substitution
Peptide T1-898(G16R), modeling a Gly-to-Arg mutation,
shows a low thermal stability (Tm ~ 7
C) compared to the
control T1-898 (Tm ~ 35
C) and other mutant peptides,
and it was suggested that this peptide did not fold
completely even at low temperature (35). In the HSQC spec-
trum at 0C, G13 shows no triple-helical resonance,
indicating that peptide T1-898(G16R) does not adopt
a triple-helical conformation in the middle, near the substi-
tution site (Fig. 2 A). Both triple-helical and disordered reso-
nances are present for the residues at both ends of this
peptide, G7 and G28, and these resonances have the same
chemical shifts as G7 and G28 in other T1-898 peptide vari-
ants. Even though triple-helical resonances are observed for
both end residues, it is not clear whether some molecules are
folded at only one end (C- or N-terminus) or whether
there are molecular species with both folded ends but
a disordered or distorted middle region. Peptide T1-
898(G16D) shows a similar low Tm value, and an HSQC
spectrum similar to that of T1-898(G16R), with the absence
of a trimer resonance for G13 (Fig. S1 A). Reduced diffusion
coefficients of peptides T1-898(G16R) and T1-898(G16D)
at 0C also indicated the presence of PFTs, although the
measurements may be less accurate due to overlapping of
the resonances corresponding to the disordered state
(Fig. 3 A and Fig. S1 B).
To promote folding through the Gly-to-Arg mutation site,
the design that was used to successfully complete triple-
helix formation in the presence of a Gly-to-Ser substitution
was applied to the T1-898(G16R) peptide. We were
surprised to find that replacing GPO(GAO)3 with (GPO)4
at the N-terminus reduced the stability of the new peptide,
GPOT1-898(G16R), to 5C (Table S1). This lowering ofFIGURE 2 Effect of Gly-to-Arg substitutions in
different neighboring-sequence environments.
Shown are 1H-15N HSQC spectra of T1-
898(G16R) (A), GPOT1-898(G16R) (B), GAAT1-
898(G16R) (C), and GAAT1-898(G16R) after
~20 h in 100% D2O (D) at 0
C. The peaks corre-
sponding to the disordered and triple helical states
are denoted by superscripts D and T, respectively.
Minor disordered resonances arise due to cis-trans
isomerization in the unfolded state of the Pro/Hyp-
rich chains (49). After ~20 h in D2O, the disordered
peaks of Gly in GAAT1-898(G16R) have
decreased intensities compared with the triple-
helical peaks of Gly, as the NH of Gly in the disor-
dered state exchanges much faster than those in the
triple helix conformation.
Biophysical Journal 101(2) 449–458
FIGURE 3 NMR diffusion measurements of
T1-898(G16R), GPOT1-898(G16R), and GAAT1-
898(G16R). Histograms of the residue-specific
translational diffusion coefficients of 15N-labeled
residues in disordered states for peptide T1-
898(G16R) (A), GPOT1-898(G16R) (B), and
GAAT1-898(G16R) (C). Diffusion coefficients at
0C are normalized to those at 40C (20C for
GPOT1-898(G16R)). The black dashed lines
represent the normalized diffusion coefficients for
M (theoretically with a value of 1) and native
trimer (with a value of 0.58 for G28 in peptide
T1-898(G16A)).
454 Xiao et al.stability is consistent with the HSQC spectrum at 0C,
which does not show clear triple-helical peaks for V15
and G22 (Fig. 2 B). It suggests that the peptide could not
fold through the mutation site and that only partially folded
species could exist, which is also indicated by the smaller
diffusion coefficients of disordered resonances of G7 and
V15 (Fig. 3 B). In contrast to the Gly-to-Ser mutation, the
rigid GPO triplets destabilize rather than stabilize the
triple-helix formation for this Gly-to-Arg mutation, suggest-
ing that more flexibility may be needed to incorporate the
large Arg residues within a triple helix.
Since the introduction of rigid sequences was unfavor-
able, it is possible that flexible local sequence environments
are needed to incorporate an Arg into the triple helix (19).
Thus, a peptide was designed with more flexible residues
introduced N-terminal to the Gly-to-Arg mutation. Peptide
GAAT1-898(G16R) was designed by modifying the triplet
next to the mutation site from GPV to a more flexible
GAA, and the N-terminal renucleation region was modified
from (GPO)4 to (GPO)3GAO. The thermal stability of the
new peptide (Tm ~ 13
C) is increased significantly
compared to that of the other two Gly-to-Arg peptides
(Table S1). The HSQC spectrum of the peptide at 0C
reveals a single strong triple-helical resonance for G7 and
three well dispersed triple-helical resonances for A15
(Fig. 2 C). Compared with GPOT1-898(G16R), the triple-
helical resonance for G7 in GAAT1-898(G16R) becomes
much stronger. In GPOT1-898(G16R), the A18 near the
mutation site shows only a poorly defined triple-helical
resonance, whereas the A15 in GAAT1-898(G16R), just
beside the mutation site, shows three triple-helical reso-
nances. Similar to the case for GPOT1-898(G16R), the
triple-helical resonances for G22 in GAAT1-898(G16R)
are not observed, probably due to overlapping with disor-
dered resonances. To solve the overlap problem, the peptide
is lyophilized and redissolved in 100% D2O to exchange out
the protons of the disordered state, allowing the triple-
helical resonances to be observed without overlap. The
HSQC spectrum of the peptide at 0C after ~20 h in D2OBiophysical Journal 101(2) 449–458shows three triple-helical resonances of G22 (Fig. 2 D),
which, together with triple-helical resonances for G7 and
A15, suggests that the peptide GAAT1-898(G16R) forms
a fully folded triple-helical conformation at 0C. However,
PFT may still exist for the peptide, as indicated by the small
diffusion coefficients of G7 and V15, where measurements
may be hindered by overlapped resonances (Fig. 3).Role of charge in folding for substitution of Gly
by charged residues
The effects of electrostatic interactions when a Gly is re-
placed with a charged residue are studied on T1-
898(G16R) (Table S1). Experiments were performed in
2 M NaCl to determine whether the charge repulsion of
the side chain of the Arg substitution destabilizes the
peptides. The pKa of the side-chain amino group of Arg is
12.48, and studies at pH >12.5 are not desirable, as alkaline
treatment of collagen has been shown to result in the loss of
inter- and intramolecular bonds (52,53). The ellipticity
value of NaCl-treated T1-898(G16R) decreased compared
to the peptide in PBS, but there is no change in Tm
(Fig. 4). It is clear that masking the charge did not help
the folding of T1-898(G16R). CD experiments of T1-
898(G16D) at pH 3.5 and pH 7 also indicated that charges
do not affect the molecular features of the peptide signifi-
cantly (Fig. S1 C).DISCUSSION
Missense mutations leading to substitution of a Gly in the
triple helix with a bulkier residue (Ala, Ser, Cys, Val, Arg,
Asp, or Glu) result in various OI phenotypes (1–3). Studies
have shown that the identity of the amino acid replacing Gly
is correlated with the lethality of OI (3,18,21). Gly/Ala
replacements are very underrepresented and those found
are largely nonlethal; Gly/Ser replacements are mixtures
of lethal and nonlethal; and Gly/Arg replacements at posi-
tions >178 are predominantly lethal in the a1(I) chain of
FIGURE 4 Effect of charge on peptide T1-898(G16R). CD melting tran-
sition of peptides GAAT1-898(G16R) (open circles), T1-898(G16R) (solid
squares), and GPOT1-898(G16R) (open squares) at 1 mg/mL in 20 mM
PBS buffer, pH 7, and T1-898(G16R) (inverted triangles) at 2 M NaCl.
NMR Studies of Peptide Models of OI 455type I collagen (3,9). Computational analysis also indicates
a relationship between the degree of conformational pertur-
bation in terms of hydrogen bonding and the identity of the
residues near the mutation site (18,19,54). However, the
molecular mechanism for this correlation is still poorly
understood. It is known that OI mutations in collagen delay
triple-helix folding (55,56). X-ray and NMR studies have
shown that Gly-to-Ala and Gly-to-Ser mutations locally per-
turb the triple-helix structure and register in collagen model
peptides (17,24,32).
Here, NMR diffusion techniques were utilized to investi-
gate low-level populations of partially folded species in a set
of triple-helical peptides with different Gly substitutions.
Interpretation of the diffusion data is based on the model
assumption that partially folded intermediate may exist in
equilibrium with M and FT, and the chemical shifts of resi-
dues in the unfolded region of the PFT intermediate are
totally overlapped with those in the M state. This model
assumes slow exchange rates between PFT, M, and FT.
Although this is largely a qualitative model, it allows us to
investigate how the sequence environment affects incorpo-
ration of the residue replacing Gly within the triple helix.
The peptide set based on T1-898 models a Gly substituted
by Ala, Ser, Asp, and Arg in a defined sequence environ-
ment (Table S1). NMR HSQC and diffusion studies on
this set of peptides show that an Ala can be incorporated
into the triple helix at 0C but that, at least in some molec-
ular species, the triple helix is partially unfolded in the
middle at the mutation site (Fig. 5). The Ser could also be
incorporated into the T1-898 triple helix but a relatively
larger proportion of species with a folded C-terminus but
disordered N-terminus and central region was found at
0C (Fig. 5). It seems that the small residues Ala and Ser
can be tolerated within a triple-helix conformation only at
the expense of generating some species with central orterminal disorder in equilibrium with the fully folded
species. However, introduction of Arg or Asp as a Gly
replacement does not allow complete triple-helix formation
and results in partially folded molecules (Fig. 5). The more
severe OI phenotype caused by Arg/Asp replacements
compared with Ala/Ser replacements of Gly in the Gly-
Xaa-Yaa repeating sequence could relate to the folding diffi-
culty seen in these peptide models, where the short length
leads to exaggerated structural consequences.
A relationship is seen between the requirement for a good
nucleation sequence at both ends of the peptide and success-
ful triple-helix folding when a Gly is replaced by another
residue near the center. With a C-terminal (GPO)4 end, the
presence of an N-terminal GPO(GAO)3 sequence allowed
successful incorporation of Ala, whereas a Ser could only
be incorporated with the more stabilizing (GPO)4
N-terminus. However, we were surprised to find that addi-
tion of the N-terminal (GPO)4 does not promote complete
triple-helix formation when an Arg is present, suggesting
the need for strong renucleation and, in the case of large
residues, an additional requirement of local flexibility
(Fig. 5). Modification of the triplet next to the mutation
site from GPV to GAA and of the N-terminal renucleation
sequence from (GPO)4 to (GPO)3GAO to make a more flex-
ible local environment, led to some fully folded triple helix
in the presence of a Gly/Arg mutation (Fig. 5). The pres-
ence of the bulky V15 residue next to Arg may hinder the
modifications needed to incorporate the Arg, which may
be aided when a more flexible environment is introduced.
Thus, it appears that a balance between stabilizing
sequences, strong renucleation, and local flexibility needs
to be achieved for accommodation of bulky residues within
triple-helical peptides. Our data suggest that how far the
structural perturbation extends along the chain in the mutant
collagen depends on the residue replacing Gly, and that this
could affect the interactions of mutant molecules within
fibrils with proteoglycans. The larger substituting residues
lead to an increased population of PFTs, with larger
unfolded regions for Arg > Ser > Ala. The presence of
partially folded species in model peptides is likely to reflect
a difficulty in triple-helix folding around a mutation, and
this could impact recognition and degradation, triggering
the unfolded protein response in the endoplasmic reticulum.
The destabilizing effects of Gly mutations are magnified
in peptide models compared to the consequences of these
mutations in OI collagens. The shorter length of the peptides
(~10 triplets vs. 338 triplets in type I collagen) and their
imino-acid-rich nature (~40–66% imino acid vs. ~20%
imino acids in type I collagen) are both likely to be factors
in the sensitivity of peptides to Gly substitutions. This is
consistent with results showing that the degree of destabili-
zation of (Gly-Pro-Hyp)8 peptides strongly depends on the
identity of the residue replacing Gly, whereas Makareeva
et al. found no relation between the decrease in thermal
stability of different OI collagens and the identity of theBiophysical Journal 101(2) 449–458
FIGURE 5 Effect of different Gly substitutions
on the equilibrium conformations. Peptide T1-
898 forms a fully folded triple-helix conformation.
When Gly is replaced by Ala, the Ala residue is
incorporated into a fully folded triple helix; but
in some molecular species, the trimer is partially
unfolded in the middle at the mutation site. A
Gly-to-Ser substitution results in the presence of
some partially folded species with unfolding at
the N-terminus, but replacing the N-terminal
region by a stabilizing/stronger renucleation se-
quence, (GPO)4, leads to fully folded triple helix.
Introduction of Arg prevents complete triple-
helix formation, leaving only partially folded
species. A stabilizing/stronger renucleating se-
quence, (GPO)4, at the N-terminal alone does not
help the peptide to fold through the mutation site,
whereas addition of flexible residues near the
mutation site in addition to a stabilizing N-terminal
sequence can incorporate the Arg residue into
a fully folded triple helix.
456 Xiao et al.residue replacing Gly (15,21). The ability to characterize the
molecular consequences of a Gly substitution in peptides,
together with the amplification of structural effects, can
contribute insights about OI mutations. In collagen, the
long stretches of Gly-Xaa-Yaa sequences on both sides of
a mutation must facilitate complete triple-helix formation,
although difficulties may arise when the mutation near the
C-terminus or the N-terminus is affected by factors seen
in these studies. In addition, all peptides studied here are
homotrimers, with Gly substitutions in all three chains,
whereas type I collagen from OI patients represents
a mixture of molecular species containing mutations in no
chains, one chain, or two chains. However, studies of heter-
otrimer peptides containing different numbers of mutant
chains (57), and recent studies on bacterial collagen models
with mutations in all three chains (58), suggest that the
consequences of having collagen molecules with three
mutant chains is not dramatically different from the case
with just one or two mutant chains. The advantage of char-
acterizing the well-defined, homogeneous peptide mole-
cules containing mutations in all three chains is important
and likely to be relevant to collagen diseases.SUPPORTING MATERIAL
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